Expression of the transcription factor NFAT2 in human neutrophils: IgE-dependent, Ca2+- and calcineurin-mediated NFAT2 activation by Vega Rioja, Antonio et al.
2328 Research Article
Introduction
Transcription factors of the ‘nuclear factor of activated T cells’
(NFAT) family are thought to play an important role in immune
responses by regulating the expression of a variety of inducible
genes such as those encoding interleukin (IL)-2, interferon-,
tumour necrosis factor  (TNF), and cyclooxygenase 2
(COX2) (Hogan et al., 2003; Im and Rao, 2004). Five members
of the NFAT family have been identified to date. Four of them,
including NFAT1 (also called NFATp or NFATc2), NFAT2
(NFATc or NFATc1), NFAT3 (NFATc4) and NFAT4 (NFATx
or NFATc3), share a similar DNA-binding domain, and are
modulated by the Ca2+-dependent phosphatase, calcineurin
(CaN) (Hogan et al., 2003; Im and Rao, 2004). Another
member, NFAT5 (also known as TonEBP or NFATz), is Ca2+-
and CaN-independent and differs significantly in its structure
from the other family members (Aramburu et al., 2006).
It is well known that NFAT members show restricted
patterns of expression in a variety of organs, tissues and cell
types (Rao et al., 1997). Regarding the immune system,
particular NFAT protein isoforms are expressed in its different
cell types; thus, NFAT1 is expressed in unstimulated
monocytes and macrophages (Wang et al., 1995; Shaw et al.,
1995), mast cells (Shaw et al., 1995), eosinophils (Jinquan et
al., 1999), B cells (Timmerman et al., 1997), T cells (Lyakh et
al., 1997) and NK cells (Shaw et al., 1995); NFAT2 is found
in RAW 264.7 only after treatment with soluble RANKL
(Takayanagi et al., 2002), basophils (Schroeder et al., 2002),
mast cells (Hock and Brown, 2003), B cells (Timmerman et
al., 1997), T cells (Lyakh et al., 1997), and NK cells (Aramburu
et al., 1995); NFAT4 has been reported in eosinophils (Jinquan
et al., 1999), B cells (Timmerman et al., 1997) and T cells
(Lyakh et al., 1997). Finally, the presence of NFAT5 has been
reported only in T cells (Trama et al., 2000).
NFAT mRNA levels often do not show a direct relationship
with the intracellular amounts of their protein products
(Schroeder et al., 2002; Trama et al., 2000), and most studies
report separate analyses of the different NFAT protein isoforms
and their transcripts. NFAT1 constitutive expression at the
mRNA and protein levels has been reported in many cell types
(Shaw et al., 1995; Aramburu et al., 1995; Wang et al., 1995;
Jinquan et al., 1999; Lyakh et al., 1997). NFAT2 mRNA and
protein are expressed in a more-restricted fashion, and in most
cases their synthesis is induced only upon cell stimulation with
immune complexes or with ionomycin plus phorbol ester
(Lyakh et al., 1997). The NFAT3 protein has never been
detected in immune-system cells, although its mRNA
transcript is expressed, albeit scarcely, in peripheral blood
lymphocytes (PBLs) (Hoey et al., 1995). As for NFAT4, both
NFAT (nuclear factors of activated T cells) proteins
constitute a family of transcription factors involved in
mediating signal transduction. The presence of NFAT
isoforms has been described in all cell types of the immune
system, with the exception of neutrophils. In the present
work we report for the first time the expression in human
neutrophils of NFAT2 mRNA and protein. We also report
that specific antigens were able to promote NFAT2 protein
translocation to the nucleus, an effect that was mimicked
by the treatment of neutrophils with anti-immunoglobulin
E (anti-IgE) or anti-Fc-receptor antibodies. Antigens,
anti-IgE and anti-FcRs also increased Ca2+ release and the
intracellular activity of calcineurin, which was able to
interact physically with NFAT2, in parallel to eliciting an
enhanced NFAT2 DNA-binding activity. In addition,
specific chemical inhibitors of the NFAT pathway, such as
cyclosporin A and VIVIT peptide, abolished antigen
and anti-IgE-induced cyclooxygenase-2 (COX2) gene
upregulation and prostaglandin (PGE2) release, suggesting
that this process is through NFAT. Our results provide
evidence that NFAT2 is constitutively expressed in human
neutrophils, and after IgE-dependent activation operates as
a transcription factor in the modulation of genes, such as
COX2, during allergic inflammation.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/120/14/2328/DC1
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the mRNA and the protein are constitutively expressed in
several organs and immune-system cells (Lyakh et al., 1997;
Hoey et al., 1995; Ho et al., 1995). NFAT5 mRNA is
constitutively expressed at significant levels in the thymus and
in peripheral lymphocytes, and the protein has been detected
in splenocytes and peripheral T lymphocytes after treatment
with ionomycin plus phorbol ester (Trama et al., 2000).
In addition to the restricted patterns of expression shown by
NFATs, their activity is controlled through modulation of their
subcellular localisation, and of their DNA-binding and
transcriptional transactivation capacities.
To date, the expression of NFAT proteins or of their
encoding mRNAs has not been evaluated in neutrophils (Wang
et al., 1995; Carballo et al., 1999; Yang et al., 2003). In these
cells, NF-B is the only transcription factor reported to be
involved in CaN-mediated processes with its transcriptional
regulatory capacity being modulated through the activation of
the I-B kinase (Frantz et al., 1994). Since it is unknown
whether NFATs are expressed in neutrophils, in the present
study we have investigated the potential presence of the five
NFAT protein isoforms and their corresponding mRNAs in
human peripheral neutrophils, as well as the mechanisms
mediating NFAT activation upon antigen, anti-IgE or anti-FcR
challenge in neutrophils from allergic patients. The potential
modulatory roles of Ca2+ and/or CaN as signal-transducing
intermediaries between IgE receptors and the NFAT
transcription factor, and the functional role of this transcription
factor, were also addressed.
Results
Expression of NFAT mRNAs in human neutrophils
We carried out conventional RT-PCR analysis using specific
primers for the five known NFAT isoforms in order to evaluate
their expression at the mRNA level in highly purified human
neutrophils. RNA extracted from neutrophils from healthy
donors and allergic patients was analysed in parallel with RNA
from activated PBLs or activated Jurkat T cells. As shown in Fig.
1A, mRNAs of NFAT1, NFAT2, NFAT4 and NFAT5 were
readily detected in unstimulated human neutrophils. Conversely,
NFAT3 mRNA expression was not detected in neutrophils,
whereas it was found in PBLs, as previously described (Hoey et
al., 1995). This finding was used as an internal control of no
contamination with PBLs in our neutrophil population. mRNA
amplification of the Charcot-Leyden crystal protein was also
assayed in order to exclude eosinophil and basophil
contamination (Fig. 1B) (Gomolin et al., 1993). In addition, the
amounts of NFAT1, NFAT2, NFAT4 and NFAT5 mRNAs
(compared with human PBLs) were measured by real-time PCR
(Fig. 1C). We found that NFAT2 was the predominant NFAT
isoform expressed by neutrophils. In these cells, NFAT2 mRNA
expression was ~23% that of PBLs (ratio NFAT2:2-
microglobulin). Unlike NFAT2 mRNA, those of NFAT1, NFAT4
and NFAT5 were detected only in very small amounts. In all
cases, no statistically significant differences were found between
samples from allergic and healthy subjects.
NFAT2 protein is expressed in human neutrophils
The expression of NFAT1, NFAT2, NFAT4 and NFAT5 protein
isoforms in human neutrophils was characterised by western
blotting analysis, using specific, non-cross-reactive antibodies
(Abs). Whole-cell extracts from unstimulated neutrophils were
analysed in parallel with extracts from activated PBLs and
Jurkat T cells. Fig. 2A shows that NFAT1 protein was not
detected in neutrophils, as previously described (Wang et al.,
1995), whereas PBLs expressed one major NFAT1 isoform of
~130 kDa, as previously described (Lyakh et al., 1997). The
NFAT2 isoform was found as a single band of ~85 kDa, with
no differences of expression between neutrophils from healthy
donors and allergic patients. PBLs and Jurkat T cells exhibited
one additional NFAT2 isoform of ~140 kDa, as previously
described (Lyakh et al., 1997). The NFAT4 isoform was not
detected in neutrophils, but it was detected in Jurkat T cells as
a band of ~155 kDa, as previously described (Lyakh et al.,
1997). The NFAT5 isoform was not detected in neutrophils, but
it was detected in PBLs and Jurkat T cells as a band of ~170
kDa, as previously described (Trama et al., 2000). Further
analysis, performed using two-colour flow cytometry staining
(Fig. 2B) showed that NFAT2 was expressed in 87-90% of
CD66+ cells, which are neutrophils (Borregaard and Couland,
1997).
Fig. 1. Analysis of NFAT mRNA expression in
human neutrophils. Total RNA was extracted
from highly purified unstimulated neutrophils
from both human healthy donors (N1-N3) and
human allergic patients (N4-N6), as well as from
PBLs (L) and Jurkat T cells (J) stimulated with
100 nM PMA plus 500 nM ionomycin, and from
highly purified eosinophils (E) used as positive
and negative controls. (A,B) RNA samples were
analysed by conventional RT-PCR, using specific
primers for the amplification of the indicated
NFAT isoform transcripts (A), or of the Charcot-
Leyden crystal protein (C-L) transcripts (B).
Results from amplification of the 2-
microglobulin (2m) housekeeping gene
transcript are shown in both panels. (C) RNA was
isolated from neutrophils from allergic patients
(AP) or healthy donors (HD) or from PBLs (L).
The levels of NFAT1, NFAT2, NFAT4 and NFAT5 mRNAs were analysed by real-time PCR analysis as indicated in the Materials and Methods
section. The levels of mRNAs were standardised against the level of 2-microglobulin (2m) mRNA. Values are mean ± s.e.m. from eight
individuals in each group.
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Since some NFAT isoforms exhibit inducible synthesis (Rao
et al., 1997; Aramburu et al., 1995; Takayanagi et al., 2002;
Lyakh et al., 1997; Trama et al., 2000), we next examined the
expression of NFAT1, NFAT2, NFAT4 and NFAT5 protein after
treatment of neutrophils with NFAT inducers of transcription,
such as ionomycin and/or phorbol ester, with negative results
(data not shown). NFAT3 mRNA was not detected after
stimulation of neutrophils with anti-IgE Abs, or the
aforementioned classic NFAT inducers (data not shown).
Antigens, anti-IgE and anti-FcRs elicit NFAT2 nuclear
translocation
We next investigated the effects of the classic activators of
NFAT (ionomycin and phorbol ester) and the cytokines IL4 and
IL5 upon NFAT2 nuclear translocation. No activation of
NFAT2 was found in neutrophils, as its was absent from
nuclear extracts in all cases (data not shown). Negative results
were similarly obtained when we assessed the effects of other
agonists eliciting diverse neutrophil functions, such as IL10, E.
coli lipopolysaccharide, TNF, granulocyte macrophage-
Journal of Cell Science 120 (14)
colony stimulating factor (GM-CSF), and platelet-activating
factor (PAF), by themselves and in different combinations –
conditions under which no NFAT2 nuclear translocation was
found to occur (data not shown). Since there are reports
showing the involvement of an IgE-dependent mechanism in
NFAT2 translocation to the nucleus in basophils and mast cells
(Schroeder et al., 2002; Hock and Brown 2003), we set out to
examine whether the challenge of human neutrophils from
allergic patients with anti-IgE Abs or specific antigens was able
to promote nuclear translocation of NFAT2. Fig. 3A illustrates
the occurrence of NFAT2 nuclear accumulation in neutrophils
from allergic donors, with a concomitant disappearance of this
protein from the cytosolic fraction upon anti-IgE Ab treatment.
No effect was observed, however, when neutrophils were
treated with non-specific goat IgG. The results observed with
anti-IgE Abs cannot be ascribed to an induction of NFAT2
protein synthesis, because the treatment with stimulus along
the course of the experiments did not affect the protein levels
in whole-cell lysates (Fig. 3B).
Fig. 4 shows the response to specific antigens. Neutrophils
from three patients who were allergic-sensitised to either Olea
Fig. 2. Expression of the NFAT2 protein isoform in human
neutrophils. (A) The potential presence of the five NFAT isoforms
was analysed by western blotting of whole-cell extracts from
unstimulated neutrophils obtained immediately after their isolation
from both human healthy donors (N1-N3) and human allergic
patients (N4-N6), as well as from PBLs (L) and Jurkat T cells (J)
stimulated with 100 nM plus 500 nM ionomycin used as positive
controls. -actin was used as an internal control to verify that equal
amounts of protein were loaded per lane. All blots shown are
representative of at least three independent experiments in each
group of individuals, with similar results. (B) Flow cytometry
analysis of NFAT2 expression in neutrophils isolated from an allergic
patient (left panel) and a healthy donor (right panel). After isolation,
two-colour flow cytometry analysis of CD66b and NFAT2 expression
was performed. Results obtained are expressed as the percentage of
double-positive (CD66b+ and NFAT2+) cells. Results shown are
representative of at least three independent experiments in each
different group of individuals.
Fig. 3. Anti-IgE-elicited NFAT2 nuclear translocation in human
neutrophils. Constitutive NFAT2 expression in human neutrophils.
(A) Neutrophils isolated from an allergic patient were stimulated
with 10 g/ml anti-IgE (-IgE) for the indicated times (up to 6
hours), or incubated with 10 g/ml non-specific goat IgG (IgG) for 4
hours. Then, nuclear and cytosolic extracts were obtained.
(B) Whole-cell extracts were obtained immediately after neutrophil
isolation from an allergic patient (basal), or neutrophils were cultured
in the absence or presence of 10 g/ml anti-IgE (-IgE) for the
indicated times (up to 24 hours), and then whole-cell extracts were
obtained. Cellular, cytosolic and nuclear NFAT2 levels were analysed
by western blotting, using anti-human NFAT2-specific Abs. -actin
was used as an internal control. The blot shown is representative of
three independent experiments with similar results. Histograms
above each lane show the mean (± s.e.m.) values quantified from the
blots from three separate experiments.
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europaea (T9; Fig. 4A), cat epithelium (E1; Fig. 4B) or
Artemisia vulgaris (W6; Fig. 4C) showed a clear translocation
of NFAT2 into the nucleus upon incubation with the specific
antigens to which the patients were sensitised (i.e. T9 in Fig.
4A, E1 in Fig. 4B, and W6 in Fig. 4C). However, when
neutrophils were cultured with antigens other than those
eliciting an allergic response by the corresponding donor, the
NFAT2 protein did not translocate to the nucleus (Fig. 4). The
specificity of this response to antigens was further assessed in
neutrophils from subjects without any allergic pathology. In
this case, none of the antigens tested was found to elicit NFAT2
nuclear translocation (data not shown).
Since previous studies have demonstrated the presence of the
three forms of the IgE receptor in human neutrophils (Gounni
et al., 2001), the next experiments were performed in order to
identify the main IgE receptor(s) involved in antigen-induced
or anti-IgE-induced NFAT2 nuclear translocation. Fig. 4D
illustrates that NFAT2 nuclear translocation was mainly
observed when neutrophils from an allergic patient were
treated with Abs directed against galectin-3 (also known as
Mac-2; clone A3A12) and FcRI (clone CRA1). Conversely,
the addition of the Ab directed against FcRII (also known as
CD23; clone 9P.25) had only a weak effect. We used mouse
IgG1 as isotype control (Fig. 4D).
Ca2+ and CaN modulate NFAT2 nuclear translocation
It is well known that elevated Ca2+ levels are a requirement
for NFAT nuclear translocation (Clipstone and Crabtree, 1992;
Liu et al., 1991; Crabtree, 1999). In this regard, we next
examined the effects of the IgE-dependent neutrophil
activation on Ca2+ mobilisation in human neutrophils from
allergic patients. As we previously reported (Monteseirín et
al., 1996), acute application of anti-IgE Abs or G3 to
neutrophils from an allergic patient sensitised to this antigen
elicited a rapid and strong cytosolic Ca2+ accumulation (Fig.
5A, 1 and 2), in a magnitude lower than that obtained with the
classic agent N-formyl-methionyl leucyl-phenylalanine
(fMLP) (Fig. 5A, 3). Furthermore, when neutrophils were
challenged with Abs against galectin-3 (Fig. 5A, 4) and FcRI
(Fig. 5A, 5), an increase of intracellular Ca2+ was detected,
which was well-correlated with the effect of these Abs upon
NFAT2 nuclear translocation. The same correlation was
observed with the Ab against FcRII, which had only a weak
effect on Ca2+ mobilisation (Fig. 5A, 6). We used mouse IgG1
as isotype control, without effect (data not shown).
One of the targets of calcium mobilisation is CaN
(phosphatase 2B), which, in a calcium-dependent manner,
dephosphorylates cytosolic NFAT to translocate it to the
nucleus (Loh et al., 1996). Since we have previously shown
that CaN is expressed by human neutrophils (Carballo et al.,
1999), we aimed our experiments at analysing whether IgE-
dependent activation could modulate CaN activity in human
neutrophils. To assess this possibility, CaN activity was here
assayed in the presence of anti-IgE or specific antigens. It was
found that this treatment actually led to a significant increase
in CaN activity, with maximal levels being reached after 30
minutes of anti-IgE or antigen treatment, and remaining high
for at least 4 hours (Fig. 5B). No effect was observed, however,
when neutrophils were treated with non-specific goat IgG. This
prompted us to study whether IgE-dependent NFAT2 nuclear
translocation was dependent on CaN activity. As shown in Fig.
6A,B, in anti-IgE-activated neutrophils from an allergic
patient, the CaN inhibitor, cyclosporin A (CsA), and cell-
permeable VIVIT peptide, an inhibitor of CaN and NFAT
interactions (Aramburu et al., 1999), prevented – in a
concentration-dependent manner – the translocation of NFAT2
to the nucleus.
Given this negative effect of CsA and VIVIT peptide on IgE-
dependent NFAT2 nuclear translocation, and that anti-IgE
enhanced CaN activity, we set out to examine the possibility
of physical interaction between CaN and NFAT2. The
coimmunoprecipitation results shown in Fig. 6C illustrate that
these were indeed two interacting molecules, as both NFAT2
and the two CaN subunits, A and B, could be precipitated
together by using either anti-CaN or anti-NFAT2 Abs.
Fig. 4. Anti-FcRs- and antigen-elicited NFAT2 nuclear translocation
in human neutrophils. Neutrophils from three allergic patients
sensitised to either T9 (A), E1 (B) or W6 (C) were stimulated for 4
hours with 10 g/ml anti-IgE (-IgE) or with the indicated specific
antigens (W6, D1, D2, G3, T9, E1 or E2) at 10 g/ml. (D) Neutrophils
from an allergic patient were incubated with 5 g/ml anti-FcRII
(-FcRII), anti-Mac-2 (-Mac-2), or anti-FcRI (-FcRI) Abs or
mouse IgG1 for 4 hours at 37°C. Then, nuclear extracts were
obtained, and NFAT2 levels were analysed by western blotting, using
anti-human NFAT2-specific Abs. Equal amounts of protein were
loaded per lane. Histograms above each lane show the mean
(± s.e.m.) values quantified from the blots from three separate
experiments.
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Antigens and anti-IgE elicit NFAT2 DNA binding: role of
CaN
To assess whether neutrophil NFAT proteins were able to form
competent DNA-binding complexes, we used an NFAT
oligonucleotide as a probe in gel retardation assays carried out
with nuclear extracts obtained from anti-IgE-stimulated
neutrophils. The formation of a DNA-protein complex elicited
by anti-IgE treatment was found to occur in a time-dependent
manner, being detected after 0.5 hours of treatment and
persisting for at least 4 hours (Fig. 7A). The formation of the
radiolabelled complex was specifically competed for by a 100-
fold molar excess of the cold NFAT probe. Since the NFAT2
protein is the only isoform constitutively expressed in
neutrophils, its binding specificity was further verified by using
a specific anti-NFAT2 monoclonal Ab. As also shown in Fig.
Journal of Cell Science 120 (14)
7A, this Ab completely supershifted the DNA-protein complex
formed. Fig. 7B shows that maximal levels of NFAT DNA
binding were reached at a 10 g/ml dose of anti-IgE after 4
hours of treatment, and that no such effect was observed when
the cells were treated with non-specific goat IgG for 4 hours.
Therefore, present results indicate that anti-IgE treatment
increases NFAT DNA-binding activity in human neutrophils,
and that the NFAT2 protein is a constituent of the DNA-protein
complex which forms under these conditions.
The dependence of this process on CaN activity was further
evidenced by the treatment of neutrophils with CsA or cell-
permeable VIVIT peptide, which were found to prevent
antigen-dependent and IgE-dependent NFAT DNA-binding
activity (Fig. 8C).
Involvement of transcription factor NFAT2 on COX2
upregulation by antigens and anti-IgE Ab
The involvement of NFAT2 in the activation of COX2 gene
expression, and its role in inflammatory disorders, are known
(Rao et al., 1997; Iñiguez et al., 2000). We have previously
shown that COX2 expression becomes upregulated in human
neutrophils at both the mRNA and protein levels, with a
concomitant PGE2 release, in response to challenge with
specific antigens or anti-IgE Ab (Vega et al., 2006). Thus, we
next studied the involvement of this transcription factor in the
IgE-promoted COX2 gene expression, using specific inhibitors
of the NFAT pathway. As shown in Fig. 8A,B, the use of CsA
and VIVIT peptide strongly attenuated antigen-induced and
anti-IgE Ab-induced COX2 protein and mRNA expression and
the concomitant PGE2 release, indicating that this transcription
factor could be involved in IgE-dependent COX2 expression.
Discussion
NFATs constitute a family of transcription factors whose
presence has been described in virtually all cell types of the
immune system, with the exception of neutrophils. The results
described here show, for the first time a constitutive and similar
expression of the NFAT2 mRNA and protein in unstimulated
human neutrophils from allergic patients or healthy donors. No
expression of other NFAT isoforms was found at the protein
level, and very low levels, compared with those of PBLs, of
the NFAT1, NFAT4 and NFAT5 transcripts were determined by
real-time PCR, which could explain the absence, or presence
at too low levels to be detected, of the protein.
Despite the inducible behaviour of NFAT2 in many
leukocyte cell types (Lyakh et al., 1997), we show that NFAT2
protein expression was not modified after cell treatment, in
agreement with a previous report in human basophils
(Schroeder et al., 2002). Conversely, the NFAT1 protein, which
here was not found in neutrophils, has been shown to represent
the most common NFAT protein isoform, and to display a
constitutive expression pattern in a wide range of leukocyte
types (Shaw et al., 1995; Aramburu et al., 1995; Wang et al.,
1995; Jinquan et al., 1999; Lyakh et al., 1997).
Our data also indicate that challenge with specific antigens
is an effective stimulus for NFAT2 activation by neutrophils
from allergic patients. This mechanism was highly specific.
Antigens other than those that produce clinical symptoms did
not evoke NFAT nuclear translocation, and were ineffective on
neutrophils from healthy donors. Presumably, the antigen-
mediated effect occurred in an IgE-dependent manner. This
Fig. 5. Antigens, anti-FcRs and anti-IgE increase cytosolic Ca2+
levels and CaN activity in human neutrophils. (A) Fura-2-AM-loaded
neutrophils from an allergic patient sensitised to G3 were treated at
the times indicated with 10 g/ml anti-IgE (-IgE) (1), 10 g/ml G3
(2), 50 nM fMLP (3), 5 g/ml anti-galectin-3 (-galectin-3) (4), 5
g/ml anti-FcRI (-FcRI) (5), or 5 g/ml anti-FcRII (-FcRII)
(6), and cytosolic Ca2+ was spectrofluorometrically recorded for 2
minutes. Each graph is representative of a set of three experiments
that yielded similar results. (B) Neutrophils from an allergic patient
sensitised to E1 were incubated with 10 g/ml anti-IgE (-IgE),
10 g/ml E1 antigen, or unspecific goat IgG (IgG) for the indicated
times. Then, the cells were lysed, and CaN activity was assayed.
Values are the means ± s.e.m. from four separate experiments
performed in triplicate.
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hypothesis is supported by three main facts: (i) we have
previously reported the presence of specific IgE on the surface
of neutrophils from allergic patients (Monteseirín et al., 2003;
Monteseirín et al., 2004); (ii) anti-IgE Ab challenge triggered
an equivalent response to that obtained with the antigens; and
(iii) ligation of IgE receptors (mainly galectin-3 and FcRI)
with specific Abs evoked NFAT2 activation. In line with our
data, the liberation of IL8 by these cells following the
stimulation by FcRI has been demonstrated previously
(Gounni et al., 2001), and the challenge of neutrophils by
galectin-3 stimulates superoxide production (Yamaoka et al.,
1995).
We believe that both the expression of NFAT2 mRNA and
protein and the NFAT2 activation detected in our system cannot
be ascribed to possible contamination by other leukocytes for
several reasons: (1) if the effects were due to a contamination
with PBLs, we would detect NFAT3 mRNA in our neutrophil
preparations (Hoey et al., 1995); (2) if the effects were due to
a contamination with eosinophils or basophils, we would find
mRNA for Charcot-Leyden crystal protein in our neutrophil
preparations (Gomolin et al., 1993); and (3) if the effects were
due to a contamination with monocytes, we would detect
NFAT1 protein in our neutrophil preparations (Wang et al.,
1995). Furthermore, we did not detect NFAT2 mRNA in
peripheral blood monocytes (data not shown), and other
authors have shown that NFAT2 is expressed only by RAW
264.7 monocytes and/or macrophages after soluble RANKL
stimulation (Takayanagi et al., 2002).
Another goal of this study was to explore the presumptive
roles of Ca2+ and CaN in the IgE-dependent NFAT activation
in human neutrophils. We have previously shown that
intracellular Ca2+ increase occurs through an IgE- and antigen-
dependent mechanism in these cells (Monteseirín et al., 1996),
Fig. 6. Involvement of CaN in IgE-dependent
NFAT2 nuclear translocation in human
neutrophils. Neutrophils from an allergic patient
were pretreated with CsA (A) or VIVIT peptide
(B) at the indicated doses for 1 hour, and then
treated with 10 g/ml anti-IgE (-IgE) for 4
hours. Nuclear extracts were obtained, and
NFAT2 levels analysed by western blotting,
using anti-human NFAT2-specific Abs. Equal
amounts of protein were loaded per lane.
Histograms above each lane show the mean (±
s.e.m.) values quantified from the blots from
three separate experiments. (C) Whole-cell
lysates (1 mg of protein) from untreated
neutrophils from an allergic patient were
incubated at 4°C for 18 hours with anti-CaN
Abs. After immunoprecipitation (IP), the pellets
were analysed by western blotting, using anti-
NFAT2 (left upper panel). Thereafter, the blot
was stripped, and reprobed with anti-CaN (left
lower panel). Immunoprecipitation was carried
out as indicated in A, except that anti-NFAT2
Abs was used, and subsequent western blotting analysis was carried out using anti-CaN Abs (right upper panel). After stripping, the blot was
reprobed with anti-NFAT2 Abs (right lower panel). The signals directly obtained from neutrophil whole-cell lysates (80 g) subjected to
western blotting analysis without immunoprecipitation (WL) are also shown in both panels.
Fig. 7. Anti-IgE-elicited NFAT2 DNA-binding activity in human
neutrophils. Role of CaN. (A,B) Neutrophils from an allergic patient
were treated either with 10 g/ml anti-IgE (-IgE) for the indicated
times (A), or with the indicated doses of anti-IgE for 4 hours (B).
(C) Neutrophils from an allergic patient sensitised to G3 were
pretreated with 1 g/ml CsA or 50 g/ml VIVIT peptide for 1 hour,
and then treated with 10 g/ml anti-IgE (-IgE) or 10 g/ml G3
antigen for 4 hours. Nuclear extracts were then obtained, and binding
to the 32P-labelled NFAT oligonucleotide probe was assessed by
electrophoretic mobility shift assays. Incubation of neutrophils with
10 g/ml non-specific IgG for 4 hours was also carried out as a
negative control (IgG). Assays performed in the presence of 1 l of
anti-NFAT2 (Ab) or carrying a 100-fold molar excess of unlabelled
oligonucleotide (*) are also shown.
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and that CaN is expressed by human neutrophils (Carballo et
al., 1999). Moreover, CaN has been implicated in several
allergic conditions, such as atopic dermatitis (Akhavan and
Rudikoff, 2003) and asthma (Kon, 2000), and inhibitors of CaN
are being employed for the treatment of these pathological
processes (Akhavan and Rudikoff, 2003; Kon, 2000).
We have described here that, after IgE-dependent treatment,
intracellular Ca2+ mobilisation and increase of Ca2+-dependent
phosphatase CaN activity occurred in human neutrophils.
Furthermore, CaN modulated IgE-dependent NFAT2 nuclear
translocation and DNA-binding activity, as evidenced using the
CaN-interfering drugs CsA (Lee and Park, 2006; Liu et al.,
1991) or VIVIT peptide (Aramburu et al., 1999).
Prostaglandin H2 synthase (cyclooxygenase, COX) is the
rate-limiting enzyme in the conversion of arachidonic acid
into eicosanoids, i.e. PGs and thromboxanes (TXs) (Smith,
1992). COX exists in two isoforms – COX1 and COX2 – of
which COX1 is constitutively expressed in most tissues and
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appears responsible for the production of PGs under normal
physiological conditions (Smith et al., 2000), and COX2
expression is associated with inflammatory processes, such
as allergy (Profita et al., 2003). Adjacent NFAT-binding sites
are present in the promoter region of inducible genes such as
COX2 (Iñiguez et al., 2000). We have previously shown that
COX2 expression becomes upregulated in human neutrophils
at both mRNA and protein levels, with a concomitant PGE2
release, in response to challenge with specific antigens or
anti-IgE Ab (Vega et al., 2006). We now describe here that
this expression was dependent on the Ca2+-CaN-NFAT
pathway.
Collectively, our results show that NFAT2 is the only
member of the NFAT family of transcription factors expressed
by human neutrophils, and provide evidence that Ca2+ and CaN
both have a role in mediating the specific antigen- and anti-
IgE-elicited nuclear translocation through Fc receptors and
enhancement of DNA-binding activity of NFAT2. To date, only
NF-B had been implicated as a target of CaN-mediated
processes in neutrophils, its effects being exerted through the
activation of I-B kinase (Frantz et al., 1994). Recently, a new
protein preferentially expressed in neutrophils, designated
calcineurin-NFAT-activating and immunoreceptor tyrosine-
based activation motif (ITAM)-containing protein’, or CNAIP,
has been suggested to act as an intermediary molecule between
CaN and NFAT activation (Yang et al., 2003). Preferential
activation of NFAT2 is correlated with mouse-strain
susceptibility to allergenic inflammation (development of
airway hyper-reactivity, pulmonary eosinophilia, mucus cell
hyperplasia, high serum IgE levels, and increased IL4 and IL5
production) (Keen et al., 2001). Our data suggest a role for
NFAT2 in the pathogenesis of the allergic state, and provide
strong evidence that NFAT2-mediated transcriptional
regulation of genes involved in allergic responses, such as
COX2, is modulated through Ca2+ and CaN activation in human
neutrophils.
Materials and Methods
Materials
The antigens used in this work were commercially available antigen extracts,
including D1 (Dermatophagoides pteronisinus), D2 (Dermatophagoides farinae), G3
(Dactylis glomerata), T9 (Olea europaea), W6 (Artemisia vulgaris), E1 (cat
epithelium) and E2 (dog epithelium), purchased from Bial-Arístegui (Bilbao, Spain).
Goat anti-human IgE Ab and the Fix and Perm cell permeabilisation kit were from
Caltag Laboratories (Burlingame, CA). CsA, phorbol 12-myristate 13-acetate
(PMA), goat IgG, ionomycin, LPS, Fura-2 acetoxymethyl ester (AM), digitonin,
fMLP, and protein G-Sepharose beads were from Sigma-Aldrich (Madrid, Spain).
Ficoll-Hypaque, phosphate-buffered saline (PBS), RPMI 1640, heat-inactivated
foetal bovine serum, penicillin and streptomycin were purchased from Bio-
Whittaker (Verviers, Belgium). Cell-permeable VIVIT peptide was purchased from
Calbiochem (San Diego, CA). PCR primers, random primers, High Pure RNA
Isolation Kit, Taq polymerase, and the double-stranded oligonucleotide 5-
GGAGGAAAAACTGTTTCATACAGAAGCGT-3, encompassing the distal
NFAT-binding site (underlined) of the human IL2 gene promoter, were obtained
from Roche (Madrid, Spain). The synthetic phosphopeptide used as a substrate for
CaN activity assays was purchased from Peninsula Laboratories (Belmont, CA).
Mouse monoclonal Abs specific for human NFAT1 and NFAT2, and rabbit
polyclonal Abs for human NFAT5, were obtained from Affinity Bioreagents
(Madrid, Spain). Mouse monoclonal Ab specific for human COX2 was obtained
from Cayman Chemical (Ann Arbor, MI). Goat anti-mouse IgG-coated
micromagnetic beads, goat anti-mouse IgG (GAM), mouse monoclonal Abs specific
for FcRII (also known as CD23) clone 9P.25, CD9, CD14, CD203c, CD66b and
CD16 were purchased from Immunotech-IZASA (Barcelona, Spain). Mouse
monoclonal Ab specific for human NFAT4 (sc-8405) and anti--actin (sc-8432)
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and the rabbit
antiserum against CaN was kindly provided by C. B. Klee (National Institutes of
Health, Bethesda, MD). Mouse monoclonal Ab specific for FcRI ( chain) clone
AER-37 (also known as clone CRA1) was obtained from eBioscience (San Diego,
Fig. 8. Involvement of NFAT in IgE-dependent COX2 expression in
human neutrophils. Neutrophils from an allergic patient sensitised to
G3 antigen were pretreated with CsA or cell-permeable VIVIT, at the
indicated doses for 1 hour, and then incubated for 24 hours with 1
g/ml LPS or 10 g/ml anti-IgE Ab (-IgE; A) or 10 g/ml G3 (B).
COX2 mRNA levels were analysed by conventional RT-PCR, using
COX2- and GAPDH-specific primers; COX2 and -actin protein
expression was analysed by western blotting, and the levels of PGE2
were measured in the culture medium supernatants, using an enzyme
immunoassay. The values shown are the mean ± s.e.m. from three
independent assays in which each measurement was performed in
triplicate. All the experiments were performed at least in triplicate.
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CA). Mouse monoclonal Ab specific against galectin-3 (also known as Mac-2) clone
A3A12 was purchased from Abcam (Cambridge, UK). Horseradish peroxidase-
conjugated horse anti-mouse IgG and goat anti-rabbit IgG secondary Abs,
interleukins, TNF and GM-CSF were purchased from Promega (Madison, WI).
Scion Image software was purchased from Scion Corporation (Frederick, MD). All
culture reagents used in this work had endotoxin levels of 0.01 ng/ml, as verified
by the Coatest Limulus lysate assay (Chromogenix, Mölndal, Sweden).
Patients and controls
The groups studied included adult atopic patients with bronchial asthma, and healthy
non-atopic volunteer controls. The asthmatic patients had given positive results in
skin-prick (Bial-Arístegui, Bilbao, Spain) and specific-IgE (HYTEC 288, Hycor
Biomedical-IZASA, Barcelona, Spain) tests to at least one common allergenic
antigen. These subjects had not received any treatment or specific hyposensitisation,
and had not experienced episodes of asthma for at least 3 months, or respiratory-
tract infections in the 4 weeks before blood sampling. The healthy group had no
history of allergy or bronchial symptoms, and were negative for the skin-prick and
specific-IgE tests toward a battery of inhalant allergenic antigens (house-dust mites,
pollens, moulds and animal danders). This study was previously approved by the
Virgen Macarena Hospital Ethics Committee, and each subject had given prior
informed consent.
Cell isolation and culture
Human neutrophils were isolated as previously described (Böyum, 1968).
Neutrophil preparations were further purified, depleting CD9+ cells [eosinophils
(Saito et al., 1986)], CD203c+ cells [basophils (Buhring et al., 2001)], and CD14+
cells [monocytes (Wright et al., 1991)] using a magnetic cell-sorting system
(MACS) by incubation with mouse anti-human CD9, anti-human CD203c, and anti-
human CD14 Abs, and then with anti-mouse IgG micromagnetic beads. The purity
of neutrophils was on average >99%. To prepare mRNA for RT-PCR, neutrophils
were purified even further by repeating the above procedure three more times, using
anti-CD9, anti-human CD203c, and anti-human CD14 Abs each time, which
reduced contaminating eosinophils to 0.001-0.004% of the final cell population.
Monocytes, basophils and lymphocytes were not detected in the neutrophil
preparations (Fig. S1 in supplementary material). Human eosinophils and PBLs
were analogously purified by MACS. Jurkat T cells (clone E6-1) were obtained
from the American Type Culture Collection. Neutrophils were cultured in RPMI
1640 medium supplemented with 10% heat-inactivated foetal bovine serum, 2 mM
L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin, and maintained at
37°C in an atmosphere of 95% O2 and 5% CO2. Where used, CsA and VIVIT were
added 1 hour before cell-activating compounds. None of the reagents affected the
viability of the cells at the concentrations used in this work, as confirmed by the
Trypan Blue dye-exclusion test.
Nucleic acid extraction and conventional RT-PCR analysis
Total RNA was isolated from highly purified neutrophils, PBLs and Jurkat T cells
using the High Pure RNA Isolation Kit according to the manufacturer’s instructions.
Total RNA (1 g) was reverse-transcribed to first-strand cDNA using random
primers. The first-strand cDNA was amplified with primer sets for human NFAT1
(accession number: NM_173091): 5-AAACTCGGCTCCAGAATCCA-3 and 5-
TGGACTCTGGGATGTGAACT-3; NFAT2 (accession number: NM_172390):
5-GCTATGCATCCTCCAACGTC-3 and 5-AGTTGGACTCGTAGGAGGAG-
3; NFAT3 (accession number: NM_004554): 5-ACACAGCCCTATCTTCAGGA-
3 and 5-ATCTTGCCTGTGATACGGTG-3; NFAT4 (accession number:
NM_173165): 5-ACCCTTTACCTGGAGCAAAC-3 and 5-CTTGCAGTAGCG -
ACTGTCTT-3; NFAT5 (accession number: NM_173214): 5-CGTGTGTG TG -
GCTTCTATGT-3 and 5-TGCCTCTCAATCAGAGAGAG-3; Charcot-Leyden
crystal protein (accession number: NM_001828): 5-AGGAGACAACAATGTCC -
CTG-3 and 5-TCACAGCCTCAGGCTTGATT-3; glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) (accession number: J04038): 5-CCACCCATGGC -
AAATTCCATGGCA-3 and 5-TCTAGACGGCAGGTCAGGTCCACC-3; 2-
microglobulin (2m) (accession number: NM_004048.2): 5-CCAGCAGAGAA -
TGGAAAGTC-3 and 5-GATGCTGCTTACATGTCTCG-3; COX2 (accession
number: M90100): 5-TCAAATGAGATTGTGGGAAAATTGCT-3 and 5-AGA -
TCATCTCTGCCTGAGTATCTT-3. Aliquots (20 l) taken after 35 cycles were
electrophoresed on agarose gels and visualised on ethidium bromide-stained agarose
gels, and photographed under UV light.
Real-time PCR
After total RNA extraction, cDNA was synthesised as described above. Real-time
PCR was performed on a LightCycler detection system (Roche) using SYBR Green
I and the thermocycler conditions recommended by the manufacturer. PCR reactions
were carried out in duplicate in a total volume of 20 l containing 3 l of cDNA
template, 3 mM MgCl2, and 0.5 M primers. Each sample was analysed for 2-
microglobulin to normalise for RNA input amounts and to perform relative
quantifications. Several 10-fold dilutions (10–1-10–5) were checked for optimal
cycling on the LightCycler, and three of them were selected for standard curves.
The same primers described above were used for NFAT1, NFAT 2, NFAT4, NFAT5
and 2-microglobulin. Melting curve analysis showed a single sharp peak with the
expected melting temperature (Tm) for all samples.
Preparation of whole-cell extracts
For the analysis of NFAT1, NFAT2, NFAT4 and NFAT5 expression, neutrophils (107
cells), PBLs (5	106 cells), or Jurkat T cells (5	106 cells) were resuspended in 50
l of ice-cold lysis buffer (50 mM Tris pH 7.4, 10 mM EGTA, 50 mM NaCl, 1%
Triton X-100, 2 mM sodium orthovanadate, 100 M phenylarsine oxide, and the
following protease-inhibitor mixture: 10 g/ml aprotinin, 10 g/ml leupeptin, 10
g/ml soybean trypsin inhibitor, 10 g/ml N-tosyl-L-phenylalanyl-chloromethyl
ketone, 10 g/ml captopril, 1 mM phenylmethylsulphonyl fluoride, 1 mM
benzamidine, and 10 mM iodoacetamide), and vortexed for 10 seconds following
sonication for 10 seconds. For the analysis of COX2 expression, neutrophils (107
cells) were resuspended in 50 l of ice-cold lysis buffer (20 mM Hepes pH 7.9, 5
mM KCl, 0.1% Nonidet P-40, 1 mM EDTA, 1 mM DTT and 10 mM NaF,
supplemented with the same protease mixture indicated above) and vortexed for 10
seconds following sonication for 10 seconds. After centrifugation at 12,000 g for 2
minutes at 4°C, the supernatant obtained constituted the whole-cell extract. Protein
concentration was determined by the Bradford procedure.
Preparation of nuclear and cytosolic extracts
Neutrophils (107 cells) were resuspended in 100 l of buffer A (20 mM Hepes pH
7.9, 10 mM KCl, 10% glycerol, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol
(DTT), 20 mM NaF, 2 mM sodium orthovanadate, 100 M phenylarsineoxide, 2
mM diisopropylfluorophosphate and the above protease inhibitor mixture) and
incubated for 30 minutes on ice, followed by vigorous vortexing for 15 seconds.
Then, Nonidet P-40 was added to a final concentration of 0.5% and, after
centrifugation at 12,000 g for 10 minutes at 4°C, the supernatant obtained
constituted the cytosolic extract. The pellet was resuspended in high-salt buffer
(buffer A supplemented with 20% glycerol and 420 mM NaCl). Following
incubation for 30 minutes on ice, sonication for 5 seconds, and re-centrifugation as
above, the supernatant obtained constituted the nuclear extract. Protein
concentration was determined by the Bradford procedure.
Western blotting analyses
For the analysis of NFAT1, NFAT2, NFAT4, NFAT5, -actin and COX2 expression,
whole-cell extracts were separated by SDS-PAGE (80 g/lane) and
electrophoretically transferred to polyvinylidene difluoride membranes. The
membranes were probed, without need of prior blocking (Vega et al., 2004) for 2
hours at room temperature with specific Abs against the four human NFAT isoforms
above, or with Abs against human COX2 or -actin, at a 1:2000 dilution in PBS
containing 1% bovine serum albumin and 0.2% Tween 20. Then, after washing with
PBS, they were incubated for 30 minutes with horseradish peroxidase-conjugated
horse anti-mouse IgG or goat anti-rabbit IgG secondary Abs at a 1:5000 dilution.
Immunoreactive bands were visualised using an enhanced-chemiluminescence
assay, as described previously (Carballo et al., 1999). For the analysis of NFAT2
nuclear translocation, neutrophil nuclear or cytosolic fractions were subjected to
SDS-PAGE (60 g/lane) and western blotting using anti-human NFAT2 Abs, as
indicated above. Protein levels were determined by scanning densitometry analysis
using the Scion Image software. The densitometric intensities of signals from
NFAT2-immunoreactive bands are presented in arbitrary units.
NFAT2 expression analysis by flow cytometry
For intracellular detection of NFAT2 by flow cytometry, human neutrophils (2	106
cells) were incubated with Abs against a neutrophil marker, i.e. phycoerythrin (PE)-
conjugated CD66b, or the IgG1-PE isotype control Ab. Neutrophils were then fixed
and permeabilised using the Fix and Perm cell permeabilisation kit (Caltag
Laboratories), following the manufacturer’s instructions. Mouse IgG1 against
human NFAT2 was added and samples were incubated for 30 minutes. Then,
samples were washed with PBS, and incubated for 30 minutes with fluorescein
isothiocyanate (FITC)-conjugated GAM. After washing with PBS, cells were
resuspended in PBS and analysed by flow cytometry (Coulter-IZASA, Barcelona,
Spain). GAM-FITC was used as isotype control in cells when NFAT2 Ab was
omitted.
Coimmunoprecipitation analysis
Neutrophil whole-cell extracts (1 mg of protein, prepared from 108 cells as described
above) were separately incubated with 2 g of anti-NFAT2 or of anti-CaN Abs in
1 ml of lysis buffer for 18 hours at 4°C, and then with protein G-Sepharose beads
for 4 hours. The pellets were washed three times with 20 mM sodium phosphate
buffer, pH 7.0, containing the previous described protease-inhibitor mixture, and
then boiled in Laemmli sample buffer. Eluted immunoprecipitated proteins were
separated by SDS-PAGE and analysed by western blotting, using anti-NFAT2 and
anti-CaN Abs.
Intracellular Ca2+ levels
Neutrophils (1	107 cells/ml) were loaded with 2.5 M Fura-2 AM for 30 minutes
at 37°C in loading buffer (20 mM Hepes, 37 mM NaCl, 2.7 mM KCl, 1 mM MgCl2,
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1 mM CaCl2, pH 7.5). Excess Fura-2 AM was removed by washing the cells twice
with loading buffer supplemented with 0.5% (w/v) BSA. Calcium measurements
were carried out with a Shimadzu (Kyoto, Japan) RF-5301 spectrofluorophotometer
equipped with a magnetic stirrer and a thermostatically controlled cuvette holder,
with an excitation wavelength of 340 nm and an emission wavelength of 510 nm.
Maximal and minimal fluorescence (Fmax and Fmin, respectively) were determined
in the presence of digitonin and EGTA-Tris-HCl, respectively. Intracellular calcium
concentrations were calculated using the following equation:
[Ca2+]i = Kd(F–Fmin) / (Fmax–F) ,
where the Kd for Fura-2 equals 224 nmol/l.
CaN phosphatase assay
CaN phosphatase activity was measured as previously described (Carballo et al.,
1999). Reaction mixtures containing 2 M 32P-labelled phosphopeptide
corresponding to a segment of the RII subunit of cAMP-dependent kinase
(Blumenthal et al., 1986) and 80 g of whole-cell extract were incubated in a total
volume of 60 l of assay buffer (20 mM Tris, pH 8.0, 100 mM NaCl, 6 mM MgCl2,
0.5 mM DTT, 0.1 mM CaCl2, 0.5 M okadaic acid, and 0.1 mg/ml bovine serum
albumin) for 15 minutes at 30°C. The reactions were stopped by the addition of 500
l of 100 mM potassium phosphate buffer, pH 7.0, containing 5% trichloroacetic
acid. The reaction mixtures were passed through columns (500 l) of activated
Dowex cation-exchange resin, and free radiolabelled inorganic phosphate (32Pi) was
quantified in the eluates by scintillation counting. Linearity of the assays after 15
minutes of reaction was adequately verified. Assays were performed in triplicate,
and the c.p.m., measured in blank assays lacking neutrophil lysate, was subtracted.
Data are expressed as the number of pmol of inorganic phosphate released per
minutes per mg of protein.
NFAT DNA-binding activity
Electrophoretic mobility shift assays of NFAT DNA binding were performed as
described previously (Carballo et al., 1999), using as a probe the 32P-radiolabelled
double-stranded NFAT oligonucleotide indicated above. The reaction was
performed in 20 l of binding buffer (10 mM Hepes, pH 7.9, 10% glycerol, 0.1
mM EDTA, 8 mM MgCl2, 0.2 g/ml poly(dI-dC), 1 mM DTT) containing 10 g
of neutrophil nuclear extract, and was allowed to proceed for 20 minutes at room
temperature. The protein-DNA complexes were separated on 4% polyacrylamide
gels, and autoradiographs were obtained. For DNA competition assays, a 100-fold
molar excess of unlabelled oligonucleotide was added before addition of the
radiolabelled probe. For supershift assays, monoclonal Abs against NFAT2 (1 l)
were added to the nuclear extracts at 4°C, 20 minutes before starting the binding
reaction.
Prostaglandin E2 release
Neutrophils (107 cells) were incubated in 1.5 ml of RPMI medium on 24-well plates
in the presence of stimuli at the doses indicated in each case. The concentrations of
PGE2 released were measured in the culture supernatants, using the Prostaglandin
E2 Enzyme Immunoassay Kit (Cayman Chemical) according to the manufacturer’s
protocol.
Statistical analysis
Data are expressed as means ± s.e.m. Comparisons between groups were made using
one-way ANOVA. A P value of <0.05 was considered significant.
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Fig. S1. Light microscopy of neutrophils. After isolation as described in the Materials 
and methods section, cells were smeared onto poly-L-lysine-treated glass slides. 
Slides were stained with Quick Panoptic hematological dye (Química Clínica Aplicada 
S.A., Amposta, Spain) and photographed under visible light microscopy. Neutrophils 
were identified from their standard morphology and distinctive Quick Panoptic 
staining. 
 
 
